Outcome of Patients With Myelodysplastic Syndrome After Failure of Decitabine Therapy

BACKGROUND: The prognosis of patients with myelodysplastic syndrome (MDS) after decitabine failure is not known. METHODS: Data from 87 patients with MDS (n = 67) and chronic myelomonocytic leukemia (n = .20) after failure of decitabine regimens were reviewed. RESULTS: After a median follow-up of 21...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer
Main Authors: Jabbour, Elias, Garcia-Manero, Guillermo, Batty, Nicolas, Shan, Jenny, O’Brien, Susan, Cortes, Jorge, Ravandi, Farhad, Issa, Jean-Pierre, Kantarjian, Hagop
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4295788/
https://ncbi.nlm.nih.gov/pubmed/20564137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25247
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki